61 – 70 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Reduced risk of prostate cancer in infertile men compared to men with proven fertility: A nested case-control study
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.197-197(
- Contribution to journal › Published meeting abstract
-
Mark
Intermittent DHT administration enhances effect of docetaxel in a xenograft model by modulation of ER beta, AR and NEK2
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.278-278(
- Contribution to journal › Published meeting abstract
-
Mark
PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
(
- Contribution to journal › Scientific review
-
Mark
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
(
- Contribution to journal › Article
-
Mark
Nordic observational study evaluating safety and analgesic consumption in patients with advanced cancer under zoledronic acid (ZOMETA (R)) treatment: NOSAZ-interim analysis
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.232-232(
- Contribution to journal › Published meeting abstract
-
Mark
Nordic Observational Study Evaluating Safety And Analgesic Use In Patients With Advanced Cancer Under Zoledronic Acid Treatment Interim Analysis
(
- Contribution to journal › Published meeting abstract
-
Mark
Do we need PSA and early detection of prostate cancer?
(
- Contribution to journal › Article
-
Mark
The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate.
(
- Contribution to journal › Article
-
Mark
Management of advanced prostate cancer: can we improve on androgen deprivation therapy?
(
- Contribution to journal › Article
-
Mark
Delta-Like 1 (Dlk-1), a Novel Marker of Prostate Basal and Candidate Epithelial Stem Cells, Is Downregulated by Notch Signalling in Intermediate/Transit Amplifying Cells of the Human Prostate.
(
- Contribution to journal › Article